Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. Multiple treatment modalities ...

LIVER cancer is the fourth most common cancer in Malaysia and also the fourth leading cause of cancer-related deaths.

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...

By contrast, in patients with hepatocellular carcinoma (HCC ... The Barcelona Clinic Liver Cancer (BCLC) staging system was developed according to the results of cohort studies and randomized ...

including a system called the Child-Pugh score The BCLC strategy is for staging hepatocellular carcinoma (HCC). HCC is different to cancer that spreads to your liver from somewhere else in your body.

This is called secondary liver cancer or liver metastases. Doctors often use the Barcelona Clinic Liver Cancer (BCLC) staging system to help make treatment decisions for HCC. This system looks at the ...

the TIMES scores significantly outperformed existing risk stratification tools such as the TNM and BCLC systems, which are commonly used for staging and classifying HCC. Validation studies ...